In functional assays, IRF9 knockdown impaired ccRCC proliferation and migration, whereas IRF9 overexpression enhanced these malignant traits, supporting its oncogenic role in renal cancer. Here, IRF9 is linked to nonpapillary renal cell carcinoma.